January 26, 1993 |
Biopool International Inc., a Ventura-based producer of test kits for diagnosing blood, vascular and other disorders, has been granted two new patents and has nearly doubled its sales in the past year, said Michael D. Bick, chief executive officer. One of the patents is for an improved method of collecting samples used in testing blood clotting and dissolving, Bick said.
November 10, 1992
Biopool International Inc., a Ventura marketer of medical test kits sold to hospitals and laboratories, posted a third-quarter profit of $145,169 compared with a year-earlier loss of $101,444. The profit in the quarter ended Sept. 30 came as Biopool's sales more than doubled, to $1.26 million from $549,759 a year earlier. The company said the gains reflected wider distribution of its equipment and new-product introductions.
November 3, 1992 |
Biopool International Inc., a Ventura firm that produces medical diagnostic kits, has received approval from the Food and Drug Administration to market two new kits. The first, called the Minutex D-Dimer, tests patients for deep-vein thrombosis or blood clots, said Michael D. Bick, Biopool's chief executive. He said the kit is less costly and takes less time than other tests now being used.
August 4, 1992
Biopool International Inc., a Ventura marketer of medical test kits, posted a $171,713 profit for the second quarter, up from $563 a year earlier. The higher earnings in the quarter ended June 30 came as Biopool's sales more than doubled, to $1.47 million from $645,968. The company said recent agreements with additional distributors contributed to the gains.
May 19, 1992
Biopool International Inc., a Ventura provider of medical diagnostic test kits, said it earned $121,496 in the first quarter, its first operating profit since the company's founding in 1987. The profit in the quarter that ended March 31 compared with a year-earlier loss of $48,301, and came on a 68% jump in its sales, to $1.18 million from $704,200.
April 14, 1992 |
Biopool International Inc. of Ventura received approval from Mexico's Ministry of Health for the sale in that country of Biopool's blood diagnostic test kits. Dr. Michael Bick, Biopool's chief executive officer, declined to estimate how much the approval will add to his company's sales, but said, "We certainly think Mexico will become a major market for us." Biopool manufactures about 30 diagnostic kits used by hospitals and labs worldwide to test for blood and heart disorders.
April 7, 1992
Biopool International Inc., a Ventura company that makes blood diagnostic test kits, reported a fourth-quarter loss of $202,000, while sales for the quarter jumped 28% to $762,000. A year earlier, Biopool lost $287,000 on sales of $594,000. The company said the fourth-quarter loss included a $160,000 write-down on patent costs and underutilized equipment. In the year that ended Dec. 31, Biopool lost $351,000, in contrast with a loss of $650,000 for 1990. Revenue rose 14% to $2.
March 10, 1992
Biopool International Inc., a Ventura company that makes blood diagnostic test kits and other blood-related products, said it acquired Medical Diagnostic Technologies Inc. in a stock swap valued at about $1.75 million. Medical Diagnostic, based in Ventura, also makes blood diagnostic test kits. Biopool said the acquisition would broaden its product offerings, about one-third of which have received market approval from the U.S. Food and Drug Administration.